Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada

Diagnostic Microbiology and Infectious Disease

Volumn 67, Issue 4, 2010, Pages 387-391

  Mataseje, Laura F ^a   Baudry, Patricia J ^b   Zhanel, Goerge G ^b   Morck, Douglas W ^c   Read, Ron R ^c   Louie, Marie ^d   Mulvey, Michael R ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d Provincial Public Health Laboratory   (Canada)

Author keywords

AmpC; Canada; Enterobacteriaceae; Plasmids

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFAZOLIN; CEFOXITIN; CEFTIOFUR; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; DRINKING WATER; PLASMID DNA; SULFAFURAZOLE; BETA LACTAMASE;

ARTICLE; BACTERIUM ISOLATE; CANADA; COMPARATIVE STUDY; CONTROLLED STUDY; ENVIRONMENT; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; NONHUMAN; PLASMID; PRIORITY JOURNAL; SALMONELLA; TERTIARY HEALTH CARE; WATER SUPPLY; ANIMAL; ANIMAL SALMONELLOSIS; BIOSYNTHESIS; CLASSIFICATION; ENZYMOLOGY; ESCHERICHIA COLI INFECTION; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; REPLICON; SALMONELLOSIS; VETERINARY;

ANIMALS; BETA-LACTAMASES; CANADA; ENVIRONMENTAL MICROBIOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; PLASMIDS; REPLICON; SALMONELLA; SALMONELLA INFECTIONS; SALMONELLA INFECTIONS, ANIMAL;

EID: 77954754198     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2010.02.027     Document Type: Article

References (18)

1. Andrysiak A.K., Olson A.B., Tracz D.M., Dore K., Irwin R., Ng L.K., Gilmour M.W. Genetic characterization of clinical and agri-food isolates of multi drug resistant Salmonella enterica serovar Heidelberg from Canada. BMC Microbiol 2008, 8:89. and Canadian Integrated Program for Antimicrobial Resistance Surveillance Collaborative.
2. Baudry P.J., Mataseje L., Zhanel G.G., Hoban D.J., Mulvey M.R. Characterization of plasmids encoding CMY-2 AmpC beta-lactamases from Escherichia coli in Canadian intensive care units. Diagn. Microbiol. Infect. Dis. 2009, 65:379-383.
3. Baudry P.J., Nichol K., DeCorby M., Mataseje L., Mulvey M.R., Hoban D.J., Zhanel G.G. Comparison of antimicrobial resistance profiles among extended-spectrum-beta-lactamase-producing and acquired AmpC beta-lactamase-producing Escherichia coli isolates from Canadian intensive care units. Antimicrob. Agents Chemother. 2008, 52:1846-1849.
4. Blanc V., Cortes P., Mesa R.J., Miro E., Navarro F., Llagostera M. Characterisation of plasmids encoding extended-spectrum beta-lactamase and CMY-2 in Escherichia coli isolated from animal farms. Int. J. Antimicrob. Agents 2008, 31:76-78.
5. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K.L., Threlfall E.J. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 2005, 63:219-228.
6. Carattoli A., Miriagou V., Bertini A., Loli A., Colinon C., Villa L., Whichard J.M., Rossolini G.M. Replicon typing of plasmids encoding resistance to newer beta-lactams. Emerging Infect. Dis. 2006, 12:1145-1148.
7. CMY-2 plasmids carried by Salmonella enterica and Escherichia coli isolates from cattle in the Pacific Northwest. Appl. Environ. Microbiol. 2007, 73:8005-8011.
8. Garcia-Fernandez A., Chiaretto G., Bertini A., Villa L., Fortini D., Ricci A., Carattoli A. Multilocus sequence typing of IncI1 plasmids carrying extended-spectrum beta-lactamases in Escherichia coli and Salmonella of human and animal origin. J. Antimicrob. Chemother. 2008, 61:1229-1233.
9. Hopkins K.L., Liebana E., Villa L., Batchelor M., Threlfall E.J., Carattoli A. Replicon typing of plasmids carrying CTX-M or CMY beta-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob. Agents Chemother. 2006, 50:3203-3206.
10. Jacoby G.A. AmpC beta-lactamases. Clin. Microbiol. Rev 2009, 22:161-182.
11. Lindsey R.L., Fedorka-Cray P.J., Frye J.G., Meinersmann R.J. Inc A/C plasmids are prevalent in multidrug-resistant Salmonella enterica isolates. Appl. Environ. Microbiol. 2009, 75:1908-1915.
12. Mataseje L.F., Neumann N., Crago B., Baudry P., Zhanel G.G., Louie M., Mulvey M.R. Characterization of cefoxitin-resistant Escherichia coli isolates from recreational beaches and private drinking water in Canada between 2004 and 2006. Antimicrob. Agents Chemother. 2009, 53:3126-3130. and ARO Water Study Group.
13. Mataseje L.F., Xiao J., Kost S., Ng L.K., Dore K., Mulvey M.R. Characterization of Canadian cefoxitin-resistant non-typhoidal Salmonella isolates, 2005-06. J. Antimicrob. Chemother. 2009, 64:723-730. and on behalf of the Canadian Public Health Laboratory Network (CPHLN).
14. Mulvey M.R., Susky E., McCracken M., Morck D.W., Read R.R. Similar cefoxitin-resistance plasmids circulating in Escherichia coli from human and animal sources. Vet. Microbiol. 2008, 134:279-287.
15. Mulvey M.R., Bryce E., Boyd D., Ofner-Agostini M., Christianson S., Simor A.E., Paton S. Ambler class A extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. in Canadian hospitals. Antimicrob. Agents Chemother. 2004, 48:1204-1214. and Canadian Hospital Epidemiology Committee, Canadian Nosocomial Infections Surveillance Program, Health CanadaCanadian Nosocomial Infections Surveillance Program, Health Canada.
16. Papanicolaou G.A., Medeiros A.A., Jacoby G.A. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino-and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 1990, 34:2200-2209.
17. Pitout J.D. Multiresistant Enterobacteriaceae: new threat of an old problem. Expert Rev. Anti Infect. Ther. 2008, 6:657-669.
18. Winokur P.L., Vonstein D.L., Hoffman L.J., Uhlenhopp E.K., Doern G.V. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob. Agents Chemother. 2001, 45:2716-2722.